The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...

World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

A study showing that once-weekly subcutaneous semaglutide 2.4 mg (Wegovy, Novo Nordisk) produces greater long-term weight loss than once-daily injected liraglutide 3.0 mg (Saxenda, Novo Nordisk) among ...

GLP-1 drugs like Wegovy and Saxenda are now prescribed for weight loss in New Zealand. With medications like Wegovy and Saxenda now available in New Zealand for weight loss, and as their use increases ...

CLEVELAND — Most people would be overjoyed to lose enough weight to meet their goal. And there's no doubt that the new injectable diet drugs are helping many people achieve those goals. But are they ...

GLP-1 diabetes and weight loss medications like Ozempic, Wegovy and Saxenda are being investigated by the European Union for causing suicidal thoughts, and while drug manufacturer Novo Nordisk denies ...

Saxenda is a brand-name subcutaneous injection that doctors often prescribe to help some people lose weight. You should keep opened Saxenda pens in the refrigerator but dispose of them after 30 days.